Continuous Glucose Monitoring (CGM) Systems Market By Product (Sensors, Transmitters and Receivers, Insulin Pumps) End User (Homecare diagnostics, Hospitals, Others) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Continuous Glucose Monitoring (CGM) Systems Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Glucose monitoring (CGM) gadgets has been driving the market. CGM devices are minimally invasive and offer a simple and compelling approach for the management of diabetes. They can likewise identify intense changes in blood glucose level, subsequently avoiding hypoglycemic conditions. These devices encourage examination of blood glucose levels at various time interims with the assistance of a sensor. Separate readings put into to diabetes management software through a remote system enable patients to comprehend the illness better, subsequently helping them to oversee it in a more successful manner.

Market Segmentation

By product the transmitters and receivers are the most important part of these devices, they represented for the biggest share of the market. Homecare settings segment ruled the global market and is foreseen to encounter the highest CAGR over the forecast period.

Regional Insights

The North American region is anticipated to dominate the global market. Rising cases of diabetes and initiatives made by the national government to manage the disease at large are foreseen to boost the region’s growth.

By Region


North America


U.S.
Canada
Mexico


Europe

Germany
UK
France
Russia
Italy
Rest of Europe


Asia-Pacific

China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific


South America

Brazil
Argentina
Columbia
Rest of South America


Middle East and Africa

Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA




Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.


Abbott Laboratories
Animas Corporation
Ypsomed AG
Roche Diagnostics
Dexcom Inc.
Medtronic Inc.
Novo Nordisk
GlySens Incorporated


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?